Trump Admin Ends Medicaid Funding for Gender Transition Treatments for Minors

The final rule blocked federal funds for surgeries, hormones, and puberty blockers starting in October.
Trump Admin Ends Medicaid Funding for Gender Transition Treatments for Minors
Detransition advocates meet outside of the annual Pediatric Endocrine Society conference held in San Diego on May 6, 2023. John Fredricks/The Epoch Times
|Updated:
0:00

President Donald Trump on Tuesday announced that the federal government will no longer use Medicaid funds to cover gender transition surgeries and hormones for minors.

“Today, at my direction, Dr. Mehmet Oz announced that Medicaid will NO LONGER fund gender transition surgeries and hormones for minors. We are not going to pay for our innocent children to undergo these barbaric surgeries and practices, which result in unthinkable and irreversible harm to their young bodies,” Trump wrote in a post on​ Truth Social.

“Thanks to our strong position and pressure on this issue over the past year and a half, dozens of U.S. hospitals have already ended this so-called ‘gender-affirming care,’ and we expect many more to follow.”

The Centers for Medicare and Medicaid Services finalized a rule ending federal Medicaid and Children’s Health Insurance Program funding for what the agency calls “sex-rejecting procedures” on children and youth.

It covers puberty blockers, cross-sex hormones, and surgical operations.

Federal funding remains available for a tapering-off period of up to six months for children already on hormone therapy.

The rule takes effect on Oct. 13.

This story will be updated with additional details.
Google LogoMark Us Preferred on Google
Kimberly Hayek
Kimberly Hayek
Author
Kimberly Hayek is a reporter for The Epoch Times. She covers California news and has worked as an editor and on scene at the U.S.-Mexico border during the 2018 migrant caravan crisis.